1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, June 2016 (p2)

Biological Therapy Analysis & Statistics, June 2016 (p2)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

31-60 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World, Europe
Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, ...

  • Industries : Biological Therapy, Therapy, Cancer, Pathology, Biopharmaceutical
  • Countries : Europe
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin-1 or SMN1 or SMN2) - Pipeline Review, H1 2016

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin-1 or SMN1 or SMN2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin-1 or SMN1 or SMN2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Survival Motor Neuron Protein (Component Of Gems 1 or Gemin-1 ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016 Summary Global ...

  • Industries : Pathology, Therapy, Biological Therapy, Biotechnology
  • Countries : United States
Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States
Interleukin 15 (IL15) - Pipeline Review, H1 2016

Interleukin 15 (IL15) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 15 (IL15) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 15 (IL15) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 15 (IL15) targeted ...

  • Industries : Pathology, Biological Therapy, Therapy
  • Countries : World, United States
Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Biotechnology
  • Countries : World
Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : Spain, France, Italy, United Kingdom, Japan
Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016

Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Telomerase ...

  • Industries : Cancer, Pathology, Therapy, Biotechnology, Biopharmaceutical
  • Countries : United States, World
Interleukin 13 (IL13) - Pipeline Review, H1 2016

Interleukin 13 (IL13) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 13 (IL13) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted ...

  • Industries : Therapy, Pathology, Biological Therapy, Biopharmaceutical, Chronic Disease, Biotechnology
  • Countries : United States
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth Facto ...

  • Industries : Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : United States, World
Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016

Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Human Papilloma Virus (HPV) E7 Protein - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical, Cancer, Pathology, Biological Therapy
  • Countries : United States
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, ...

  • Industries : Biological Therapy, Therapy, Biopharmaceutical, Biotechnology, Cancer, Pathology
  • Countries : United States, World
HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016

HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016’, provides in depth analysis on HIV-1 Integrase (EC ...

  • Industries : Therapy
  • Countries : United States
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Biopharmaceutical, Cancer, Pathology, Biotechnology
  • Countries : United States
Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016

Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucin 1 (MUC-1 or Breast Carcinoma-Associated ...

  • Industries : Cancer, Therapy, Biopharmaceutical, Pathology, Biotechnology, Pharmaceutical
  • Countries : World, United States
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced in Hepatomas or SDF1 or Pre B cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Pathology, Biological Therapy
  • Countries : United States
Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts

Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts

  • $ 2 995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including ...

  • Industries : Biological Therapy, Biotechnology, Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States, North America
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape

  • $ 2 995
  • Industry report
  • July 2016
  • by GBI Research

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research’s latest report, "Stem Cell Therapies - Global Trends in the Competitive, Technological and ...

  • Industries : Biological Therapy
Global Cancer Therapeutics and Biotherapeutic Market Report 2016

Global Cancer Therapeutics and Biotherapeutic Market Report 2016

  • $ 2 850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Cancer Therapeutics and Biotherapeutic Report is a professional and in-depth research report on the world's major regional market conditions of the Cancer Therapeutics and Biotherapeutic industry, ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Global Cell Line Toxicology Instruments Market Research Report 2016

Global Cell Line Toxicology Instruments Market Research Report 2016

  • $ 2 850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Cell Line Toxicology Instruments Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cell Line Toxicology Instruments industry, ...

  • Industries : Biological Therapy, General Medicine and Specialty Medicine
  • Countries : World, Europe, Asia, North America
Global Therapeutic Vaccines Market Report 2016

Global Therapeutic Vaccines Market Report 2016

  • $ 2 850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Therapeutic Vaccines Report is a professional and in-depth research report on the world's major regional market conditions of the Therapeutic Vaccines industry, focusing on the main regions ...

  • Industries : Biological Therapy, Biopharmaceutical, Therapy, Biotechnology
  • Countries : World, Europe, Asia, North America
Global Stem Cell Therapies Market Research Report 2016

Global Stem Cell Therapies Market Research Report 2016

  • $ 2 850
  • Industry report
  • June 2016
  • by 9Dimen Research

2016 Global Stem Cell Therapies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Stem Cell Therapies industry, focusing on the main ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Global and Chinese Imiquimod Industry, 2016 Market Research Report

Global and Chinese Imiquimod Industry, 2016 Market Research Report

  • $ 2 800
  • Industry report
  • August 2016
  • by Prof Research

The 'Global and Chinese Imiquimod Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Imiquimod industry with a focus on the Chinese market. ...

  • Industries : Biological Therapy
  • Countries : World
Global and Chinese Therapeutic Vaccines Industry, 2016 Market Research Report

Global and Chinese Therapeutic Vaccines Industry, 2016 Market Research Report

  • $ 2 800
  • Industry report
  • July 2016
  • by Prof Research

The 'Global and Chinese Therapeutic Vaccines Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Therapeutic Vaccines industry with a focus ...

  • Industries : Biological Therapy, Biopharmaceutical, Therapy, Biotechnology
  • Countries : World
Global and Chinese Stem Cell Industry, 2016 Market Research Report

Global and Chinese Stem Cell Industry, 2016 Market Research Report

  • $ 2 800
  • Industry report
  • July 2016
  • by Prof Research

The 'Global and Chinese Stem Cell Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Stem Cell industry with a focus on the Chinese market. ...

  • Industries : Biological Therapy
  • Countries : World
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016

Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • August 2016
  • by Global Data

Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer
  • Countries : World
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • August 2016
  • by Global Data

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Mental Health, Pharmaceutical, Pathology
  • Countries : World
Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2016

Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2016" provides an ...

  • Industries : Therapy, Biological Therapy, Pharmaceutical, Biopharmaceutical, Biotechnology
  • Countries : World
Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic ...

  • Industries : Chronic Disease, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.